Amdocs Fundamentals

DOX
 Stock
  

USD 88.95  1.36  1.55%   

Amdocs Limited fundamentals help investors to digest information that contributes to Amdocs' financial success or failures. It also enables traders to predict the movement of Amdocs Stock. The fundamental analysis module provides a way to measure Amdocs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amdocs stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Amdocs Interest Expense is fairly stable at the moment as compared to the past year. Amdocs reported Interest Expense of 12.42 Million in 2021. Weighted Average Shares is likely to rise to about 126.6 M in 2022, whereas Direct Expenses is likely to drop slightly above 2.3 B in 2022.

Amdocs Debt to Equity Analysis

Amdocs' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
 2019 2020 2021 2022 (projected)
Accounts Payable110.14 M121.2 M139.38 M156.14 M
Receivables861.03 M866.82 M780.14 M737.36 M
D/E 
 = 
Total Debt 
Total Equity 
More About Debt to Equity | All Equity Analysis

Current Amdocs Debt to Equity

    
  0.24 %  
Most of Amdocs' fundamental indicators, such as Debt to Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amdocs Debt to Equity Historical Pattern

Today, most investors in Amdocs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amdocs' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's debt to equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Amdocs debt to equity as a starting point in their analysis.
   Amdocs Debt to Equity   
Share
       Timeline  
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Compare to competition

Amdocs Shareholders Equity

Shareholders Equity

4.14 Billion

Amdocs Shareholders Equity is fairly stable at the moment as compared to the past year. Amdocs reported Shareholders Equity of 4.13 Billion in 2021
According to the company disclosure, Amdocs Limited has a Debt to Equity of 0.24%. This is 99.59% lower than that of the Technology sector and significantly higher than that of the Software—Infrastructure industry. The debt to equity for all United States stocks is 99.51% higher than that of the company.

Amdocs Limited Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amdocs's current stock value. Our valuation model uses many indicators to compare Amdocs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amdocs competition to find correlations between indicators driving Amdocs's intrinsic value. More Info.
Amdocs Limited is one of the top stocks in number of employees category among related companies. It is one of the top stocks in current asset category among related companies fabricating about  67,755  of Current Asset per Number of Employees. Net Current Assets as percentage of Total Assets is likely to rise to 17.08 in 2022, whereas Current Assets are likely to drop slightly above 1.9 B in 2022.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Amdocs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amdocs' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amdocs' earnings, one of the primary drivers of an investment's value.

Amdocs Current Valuation Drivers

We derive many important indicators used in calculating different scores of Amdocs from analyzing Amdocs' financial statements. These drivers represent accounts that assess Amdocs' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Amdocs' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee14.54 K19.56 K19.19 K25.33 K22.8 K19.83 K
Revenue Per Employee163.03 K166.69 K160.68 K157.81 K142.03 K141.06 K
Average Assets5.44 B5.26 B6.07 B6.64 B7.63 B7.05 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA639.53 M775.52 M793.17 M1.03 B1.19 B1.04 B
Earnings Before Interest Taxes and Depreciation Amortization USD639.53 M775.52 M793.17 M1.03 B1.19 B1.04 B
Earnings before Tax421.54 M567.89 M583.32 M814.31 M936.45 M792.89 M
Average Equity3.53 B3.47 B3.58 B3.66 B4.21 B4.19 B
Enterprise Value8.97 B8.81 B7.58 B9.81 B11.28 B10.09 B
Free Cash Flow326.1 M528.29 M452.63 M715.37 M822.67 M730.18 M
Invested Capital823.5 M945.27 M2.3 B2.24 B2.58 B2.78 B
Invested Capital Average806.02 M915.8 M1.91 B2.23 B2.57 B2.77 B
Market Capitalization9.53 B9.27 B7.74 B9.96 B11.45 B10.65 B
Tangible Asset Value2.64 B2.62 B3.47 B3.63 B4.17 B3.91 B
Working Capital425.76 M467.64 M858.38 M763.63 M687.27 M725.92 M

Amdocs ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Amdocs Institutional Holders

Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.
Security TypeSharesValue
Fmr LlcCommon Shares12.8 M1.1 B
Massachusetts Financial Services CoCommon Shares7.1 M591.5 M
Pzena Investment Management LlcCommon Shares6.3 M528.8 M
Allspring Global Investments Holdings LlcCommon Shares5.3 M442.4 M
Lsv Asset ManagementCommon Shares4.4 M364 M
Blackrock IncCommon SharesM337 M
Nordea Investment Management AbCommon Shares2.7 M222.6 M

Amdocs Fundamentals

About Amdocs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amdocs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue273 M233.4 M
Cost of Revenue3.2 B3.1 B
Revenues4.9 B4.8 B
Revenue to Assets 0.59  0.60 
Revenue Per Employee142 K141.1 K
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 31000 people.

Amdocs Investors Sentiment

The influence of Amdocs' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amdocs. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Amdocs' public news can be used to forecast risks associated with investment in Amdocs. The trend in average sentiment can be used to explain how an investor holding Amdocs can time the market purely based on public headlines and social activities around Amdocs Limited. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Amdocs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amdocs' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amdocs' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Amdocs.

Amdocs Implied Volatility

    
  45.45  
Amdocs' implied volatility exposes the market's sentiment of Amdocs Limited stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amdocs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amdocs stock will not fluctuate a lot when Amdocs' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amdocs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amdocs' short interest history, or implied volatility extrapolated from Amdocs options trading.
Continue to Amdocs Piotroski F Score and Amdocs Altman Z Score analysis. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.9 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.